Generian Pharmaceuticals

Private

Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://www.generian.com/

Last Round

Seed

Oct 1, 2019

Total Funding Raised

$13M

Company Overview

Generian Pharmaceuticals is a preclinical biotechnology company that discovers and develops orally available small molecule therapeutics for diseases with high unmet needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

small moleculedrug discoverysmall molecule drugsbiotechnologyprotein modulationphenotypic screeningoral therapeuticspreclinical researchprotein degradationundruggable targetsdrug pipelineprotein stabilizationdrug discovery platformbiotech partneringbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Generian Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Generian Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Generian Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Oct 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Hank Safferstein

Chief Executive Officer

Executive Team

Generian Pharmaceuticals Investors

Notable investors and investment history

Generian Pharmaceuticals investors
Investor	Rounds
University of Pittsburgh Innovation Institute	Seed
UPMC Enterprises	Seed

View all Investors

Generian Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Generian Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Generian Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania

Employee Range7

Year Founded2019

Last FundingOct 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.